Results 31 to 40 of about 55,204 (263)

Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses

open access: yesFrontiers in Aging Neuroscience, 2023
IntroductionOligomeric and fibrillar species of the synaptic protein α-synuclein are established key players in the pathophysiology of Parkinson’s disease and other synucleinopathies. Increasing evidence in the literature points to prefibrillar oligomers
Elena Ferrari   +5 more
doaj   +1 more source

Complex evolutionary dynamics of massively expanded chemosensory receptor families in an extreme generalist chelicerate herbivore [PDF]

open access: yes, 2016
While mechanisms to detoxify plant produced, anti-herbivore compounds have been associated with plant host use by herbivores, less is known about the role of chemosensory perception in their life histories.
Bajda-Wybouw, Sabina   +10 more
core   +4 more sources

Interferon-γ acutely augments inhibition of neocortical layer 5 pyramidal neurons [PDF]

open access: yes, 2020
BACKGROUND: Interferon-γ (IFN-γ, a type II IFN) is present in the central nervous system (CNS) under various conditions. Evidence is emerging that, in addition to its immunological role, IFN-γ modulates neuronal morphology, function, and development in ...
Bräuer, Anja U.   +7 more
core   +1 more source

The Effects of Ionotropic GABA Receptor Blockage on the Brain in Rats with Induced Sepsis

open access: yesMolecular Neurobiology, 2023
Abstract Encephalopathy develops following sepsis, which is defined as life-threatening organ failure due to the irregular response of a host to infection. It has high mortality and morbidity rates. In this study, we aimed to investigate the effects of inflammation on brain tissue, and the effects of the gamma-aminobutyric acid-A (GABAA ...
Gulten Ates   +3 more
openaire   +3 more sources

Nitric Oxide Orchestrates a Power-Law Modulation of Sympathetic Firing Behaviors in Neonatal Rat Spinal Cords

open access: yesFrontiers in Physiology, 2018
Nitric oxide (NO) is a diffusible gas and has multifarious effects on both pre- and postsynaptic events. As a consequence of complex excitatory and inhibitory integrations, NO effects on neuronal activities are heterogeneous.
Chun-Kuei Su, Yi-Yin Chen, Chiu-Ming Ho
doaj   +1 more source

Activation of endothelial NO synthase and P2X7 receptor modification mediates the cholinergic control of ATP-induced interleukin-1β release by mononuclear phagocytes

open access: yesFrontiers in Immunology, 2023
ObjectiveThe pro-inflammatory cytokine interleukin-1β (IL-1β) plays a central role in host defense against infections. High systemic IL-1β levels, however, promote the pathogenesis of inflammatory disorders.
Katrin Richter   +16 more
doaj   +1 more source

Cocaine modulates locomotion behavior in C. elegans.

open access: yesPLoS ONE, 2009
Cocaine, a potent addictive substance, is an inhibitor of monoamine transporters, including DAT (dopamine transporter), SERT (serotonin transporter) and NET (norepinephrine transporter).
Alex Ward   +3 more
doaj   +1 more source

Ionotropic glutamate receptors mediate inducible defense in the water flea Daphnia pulex. [PDF]

open access: yesPLoS ONE, 2015
Phenotypic plasticity is the ability held in many organisms to produce different phenotypes with a given genome in response to environmental stimuli, such as temperature, nutrition and various biological interactions.
Hitoshi Miyakawa   +3 more
doaj   +1 more source

Sustained postsynaptic kainate receptor activation downregulates AMPA receptor surface expression and induces hippocampal LTD

open access: yesiScience, 2021
Summary: It is well established that long-term depression (LTD) can be initiated by either NMDA or mGluR activation. Here we report that sustained activation of GluK2 subunit-containing kainate receptors (KARs) leads to α-amino-3-hydroxy-5-methyl-4 ...
Jithin D. Nair   +8 more
doaj   +1 more source

Memantine Confers Multi-Target Protection in a Zebrafish Seizure Model: Attenuating Epileptic Behavior, GluN2A Overexpression, and Oxidative Stress. [PDF]

open access: yesJ Neurochem
Approximately 30% of epilepsy patients do not respond to current medications. In addition, the pharmaceutical industry is reducing its interest in de novo drug discovery for epilepsy. Drug repurposing offers a promising alternative. This study investigated memantine, an Alzheimer's drug, in a zebrafish model of seizures.
Zenki KC   +9 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy